GMP ONLINE CONSULTANCY
Shopping cart spacer | Your Account |
Homepage

Available Documents
spacer
Standard Operating Procedure
ChecklistsMaster Plans
Quality Contracts
spacer

spacer

OUR SERVICES
spacer
Online Consultancy
Consultancy Request
Consultancy Process
News & Trends
Newsletter
spacer

Regulation & Guides
spacer
FDA
EMEA
Regulatory Links
Organisations
Pre-Approval-Inspection
spacer

About us
spacer
Payment Methods
Company Profile
Terms and Conditions
Privacy Policy
Contact
spacer

GMP Guide
spacer
FDA
Standard Operation Procedure
spacer

Pre-Inspection Activities

Proper preparation work is vital for ensuring that your company successfully passes a PAI. It is highly recommended that preparation work starts at least 12 months before the date when you plan to contact the relevant authority.

An initial PAI meeting should be held to define the responsibilities of individual PAI team members and milestones must be set in order to monitor the progress of preparation work. Our website offers a range of tools and guides that help ensure your preparations for a PAI run smoothly. PAI protocols for drug products and active pharmaceutical ingredients have been created to systematically identify the strengths, opportunities, weaknesses and threats associated with organization, personnel, quality systems, facilities, utilities, water systems, clean steam, HVAC, gases, equipment, key raw material suppliers, manufacturing process synthesis, sieving, milling, micronisation, analytical testing, test method validation, method transfer, stability, laboratory equipment, microbiological testing, contractors/suppliers and inspection issues (» checklists). These protocols enable you to identify any potential shortcomings during the early stages of preparation work, usually 6-12 months before the submission of a new drug, and give you the opportunity to resolve the issues or finalise pending work and reports in good time.

The FDA is also increasingly focusing on the validation of computer and/or computerised systems and compliance with 21 CFR Part 11 on a risk-based evaluation. It is vital that you are well prepared in these areas (» checklists)!

Companies should be aware that preparing for a PAI is not a last-minute activity. It is clear from current warning letters that SOPs are still extremely important. One of the most likely reasons for this is the FDA’s new systematic approach. Common observations for SOPs relating to key issues such as deviation, OOS, change control and training are that they are often too convoluted or general and sometimes workers are not given sufficient training in how to implement them. Many warning letters also cite incomplete document history files or outdated SOPs. Generic SOPs are available on our website to help you avoid such pitfalls and only need to be adapted slightly to suit your company (» SOP's).

It is also advisable to organize comprehensive training for the personnel who are to participate in a regulatory authority inspection. Indeed, it is widely recognised that personnel who behave in an inappropriate manner or provide misleading information can cause inspectors to look into areas where they previously had no concerns. The same applies to the misinterpretation of questions and the use of phrases that should be avoided such as “I think”, “I suppose”, “I guess”, “normally”, “usually”, “occasionally”, or “mostly”. It is vital that all personnel who could potentially come into contact with an FDA investigator undergo proper training on how they should conduct themselves during an inspection. It is important to remember that there is a whole range of do’s and don’ts that must be followed in all circumstances.

Troubleshooting and Gap analysis conducted by the PAI team provides a further useful tool. This “organized brainstorming” meeting is designed to list all potential strengths, opportunities, weaknesses and threats. Everyone taking part in the meeting must be able to speak openly and honestly when discussing where they personally see potential risk areas or weaknesses. Senior management are often surprised by how much is already known within an organisation, but is not communicated to the people who are able to change and improve issues that may have caused problems in the past but were never resolved.

It is crucial that you closely examine the findings of any previous inspections and the commitments that were given to the agency as inspectors often use these as a starting point for their work.

Shortly before the inspection, a key contacts list should be compiled detailing the names, positions, phone numbers, mobile numbers and e-mail addresses of the most experienced personnel. This will ensure that information flows rapidly and smoothly during the hectic inspection period.

« Reasons for PAI During the Inspection »



© GMP ONLINE CONSULTANCY - Impressum - Imprint